The 12 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 73.50, with a high estimate of 85.00 and a low estimate of 64.00. The median estimate represents a +16.22% increase from the last price of 63.24.
The current consensus among 17 polled investment analysts is to Buy stock in Bristol-Myers Squibb Co. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.50
Reporting Date Oct 22
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.